STUDY OBJECTIVE: To determine the effect of propofol on skin incision at target plasma concentrations of one to 6 μg/mL on the minimum alveolar concentration (MAC) of sevoflurane. DESIGN: Prospective, randomized, single-blinded study. SETTING: Operating room of a university hospital. PATIENTS: 122 adult, ASA physical status I and II patients with cholecystitis and gastric cancer, presenting for elective abdominal surgery. INTERVENTIONS: Each group received propofol at different target-controlled plasma concentrations of 0, 1, 2, 3, 4, 5 and 6 μg/mL, respectively. The end-tidal concentration of sevoflurane was stable at a predetermined value for at least 15 minutes. Skin incision was performed after return of neuromuscular function. MEASUREMENTS: Patients were observed for gross purposeful movement for one minute after skin incision. Heart rate and mean arterial pressure were recorded before induction of anesthesia, before incision, and after incision. MAIN RESULTS: The MAC of sevoflurane when used alone was 2.2% ± 0.11%. Propofol decreased the MAC of sevoflurane by 12.3% at one μg/mL, 30.5% at two μg/mL, 35% at three μg/mL, 46.8% at 4 μg/mL, 57.7% at 5 μg/mL, and 72.7% at 6 μg/mL. The linear regression equation of the interaction between sevoflurane and propofol was Y = 2.1679 - 0.256 X, R(2) = 0.9407, where X = plasma propofol concentration, Y = sevoflurane concentration, and R(2) = correlation coefficient. CONCLUSIONS:Propofol decreases the MAC of sevoflurane in a concentration-dependent manner in adult patients.
RCT Entities:
STUDY OBJECTIVE: To determine the effect of propofol on skin incision at target plasma concentrations of one to 6 μg/mL on the minimum alveolar concentration (MAC) of sevoflurane. DESIGN: Prospective, randomized, single-blinded study. SETTING: Operating room of a university hospital. PATIENTS: 122 adult, ASA physical status I and II patients with cholecystitis and gastric cancer, presenting for elective abdominal surgery. INTERVENTIONS: Each group received propofol at different target-controlled plasma concentrations of 0, 1, 2, 3, 4, 5 and 6 μg/mL, respectively. The end-tidal concentration of sevoflurane was stable at a predetermined value for at least 15 minutes. Skin incision was performed after return of neuromuscular function. MEASUREMENTS: Patients were observed for gross purposeful movement for one minute after skin incision. Heart rate and mean arterial pressure were recorded before induction of anesthesia, before incision, and after incision. MAIN RESULTS: The MAC of sevoflurane when used alone was 2.2% ± 0.11%. Propofol decreased the MAC of sevoflurane by 12.3% at one μg/mL, 30.5% at two μg/mL, 35% at three μg/mL, 46.8% at 4 μg/mL, 57.7% at 5 μg/mL, and 72.7% at 6 μg/mL. The linear regression equation of the interaction between sevoflurane and propofol was Y = 2.1679 - 0.256 X, R(2) = 0.9407, where X = plasma propofol concentration, Y = sevoflurane concentration, and R(2) = correlation coefficient. CONCLUSIONS:Propofol decreases the MAC of sevoflurane in a concentration-dependent manner in adult patients.
Authors: Jill Singsank-Coats; Reza Seddighi; Barton W Rohrbach; Sherry K Cox; Christine M Egger; Thomas J Doherty Journal: Can J Vet Res Date: 2015-04 Impact factor: 1.310
Authors: Mary Cooter; Katherine Ni; Jake Thomas; Dhanesh K Gupta; Thomas J Hopkins; Timothy E Miller; Michael L James; Miklos D Kertai; Miles Berger Journal: Br J Anaesth Date: 2019-11-01 Impact factor: 9.166